The Global CAR T Cell Therapy Market is expected to register a CAGR of58.52% during the forecast period, with a market value of USD 346.75 Million in 2018. Chimeric Antigen Receptor (CAR) T Cell Therapy is an immunotherapy used for cancer treatment. In this therapy, T cells from patient body are isolated and inserted in the CAR gene so that the gene for the specific receptor binds ... Read more
